|By Marketwired .||
|July 24, 2014 03:00 PM EDT||
LONDON, ONTARIO -- (Marketwired) -- 07/24/14 -- McKenzie Lake Lawyers, LLP and Morganti Legal, P.C. have filed a class action lawsuit against Abbott Laboratories Ltd., Abbott Products Inc., Abbott Products Canada Inc., and Abbvie Products LLC ("Abbott"), the makers and sellers of Androgel on June 26, 2014.
Androgel is approved in Canada, since 2002, for use in the treatment of low-testosterone conditions associated with hypogonadism. It is one form of testosterone replacement therapy: other forms include injections, patches and pills. Use of these testosterone replacement therapies have been linked to an increased risk of suffering heart attacks, blood clots, strokes and death. This is the first testosterone replacement therapy class action commenced in Canada.
The Androgel Claim alleges that Abbott knew or should have known of these risks and failed to warn the public. The lawsuit also claims Abbott aggressively marketed Androgel by misleading potential users about the prevalence and symptoms of low testosterone, along with the safety and efficacy of Androgel treatment, ultimately failing to protect users from serious, life-threatening, adverse medical events.
Andrew Morganti, of Morganti Legal, P.C. says, "We believe that through this lawsuit, Abbott will be required to explain to Canadian consumers what it knew about the risks associated with using Androgel and when it first became aware of those risks."
Matthew Baer, of McKenzie Lake Lawyers explains: "In this case, as in all of these types of cases, we are concerned about whether Canadians were adequately warned of the risks associated with using this product."
It is too early to quantify the value of class member claims, but it is anticipated that the amounts are significant. Canadians, who have experienced adverse events from using Androgel, or other testosterone replacement products, are encouraged to visit www.mckenzielake.com, call 1-844-672-5666, or e-mail [email protected] for more information.
Oct. 10, 2015 01:00 AM EDT Reads: 200
Oct. 10, 2015 01:00 AM EDT Reads: 753
Oct. 10, 2015 01:00 AM EDT Reads: 236
Oct. 10, 2015 12:00 AM EDT Reads: 264
Oct. 10, 2015 12:00 AM EDT Reads: 174
Oct. 10, 2015 12:00 AM EDT Reads: 218
Oct. 9, 2015 11:15 PM EDT Reads: 206
Oct. 9, 2015 11:00 PM EDT Reads: 650
Oct. 9, 2015 10:15 PM EDT Reads: 143
Oct. 9, 2015 10:00 PM EDT Reads: 245
Oct. 9, 2015 10:00 PM EDT Reads: 453
Oct. 9, 2015 09:30 PM EDT Reads: 317
DevOps is gaining traction in the federal government – and for good reasons. Heightened user expectations are pushing IT organizations to accelerate application development and support more innovation. At the same time, budgetary constraints require that agencies find ways to decrease the cost of developing, maintaining, and running applications. IT now faces a daunting task: do more and react faster than ever before – all with fewer resources.
Oct. 9, 2015 09:00 PM EDT Reads: 416
The buzz continues for cloud, data analytics and the Internet of Things (IoT) and their collective impact across all industries. But a new conversation is emerging - how do companies use industry disruption and technology enablers to lead in markets undergoing change, uncertainty and ambiguity? Organizations of all sizes need to evolve and transform, often under massive pressure, as industry lines blur and merge and traditional business models are assaulted and turned upside down. In this new da...
Oct. 9, 2015 08:00 PM EDT Reads: 319
The web app is agile. The REST API is agile. The testing and planning are agile. But alas, data infrastructures certainly are not. Once an application matures, changing the shape or indexing scheme of data often forces at best a top down planning exercise and at worst includes schema changes that force downtime. The time has come for a new approach that fundamentally advances the agility of distributed data infrastructures. Come learn about a new solution to the problems faced by software organ...
Oct. 9, 2015 08:00 PM EDT Reads: 935